Lava Therapeutics
Creates and develops next generation γδ T cell engaging bispecific antibodies for the treatment of cancer.
HQ location
Utrecht, Netherlands
Founding location
Amsterdam, Netherlands
Website
Launch date
Employees
Market cap
$34.5m
Enterprise value
($32m)
Share price
$1.32 LVTX
Company register number
65335740
Authorizing premium user...